RE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 918
NA - Nord America 729
AS - Asia 675
SA - Sud America 87
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 14
Totale 2.472
Nazione #
US - Stati Uniti d'America 687
RU - Federazione Russa 551
SG - Singapore 276
CN - Cina 190
IT - Italia 122
BR - Brasile 66
DE - Germania 64
VN - Vietnam 54
HK - Hong Kong 52
GB - Regno Unito 36
BD - Bangladesh 30
FR - Francia 30
IN - India 30
SE - Svezia 28
FI - Finlandia 25
CA - Canada 23
NL - Olanda 17
PL - Polonia 12
JP - Giappone 10
IQ - Iraq 8
MX - Messico 7
ES - Italia 6
KR - Corea 6
AR - Argentina 5
EC - Ecuador 5
ZA - Sudafrica 5
LT - Lituania 4
TN - Tunisia 4
AT - Austria 3
BE - Belgio 3
CO - Colombia 3
ID - Indonesia 3
IE - Irlanda 3
MD - Moldavia 3
UA - Ucraina 3
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
JM - Giamaica 2
MY - Malesia 2
PH - Filippine 2
RO - Romania 2
TR - Turchia 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GY - Guiana 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 2.423
Città #
Singapore 167
Dallas 125
Ashburn 101
Moscow 77
San Jose 61
Hong Kong 49
New York 47
Beijing 42
Milan 32
Boardman 30
Council Bluffs 28
Munich 28
Shanghai 28
Los Angeles 26
Ho Chi Minh City 19
Hefei 18
Turku 18
Santa Clara 16
Lauterbourg 14
Hanoi 12
Orem 12
Rome 10
Amsterdam 9
Denver 9
Frankfurt am Main 9
São Paulo 9
Warsaw 9
Bar Harbor 8
London 8
Manchester 8
Montreal 8
Nuremberg 8
Helsinki 7
Mumbai 7
Tokyo 7
Brooklyn 6
Falkenstein 6
Pune 6
Houston 5
Hyderabad 5
Johannesburg 5
Lawrence 5
Phoenix 5
Poplar 5
Princeton 5
Seattle 5
Chennai 4
Chicago 4
Da Nang 4
Guangzhou 4
Querétaro 4
Rio de Janeiro 4
Toronto 4
Turin 4
Acalanes Ridge 3
Atlanta 3
Bari 3
Barnet 3
Belo Horizonte 3
Bologna 3
Brescia 3
Brussels 3
Bến Tre 3
Columbus 3
Dhaka 3
Dublin 3
Haiphong 3
Naples 3
Pyeongtaek-si 3
Shenzhen 3
Teramo 3
The Dalles 3
Washington 3
Wroclaw 3
Annapolis 2
Bakersfield 2
Birmingham 2
Biên Hòa 2
Buffalo 2
Cancello e Arnone 2
Canoas 2
Carpi 2
Catania 2
Cologne 2
Cortona 2
Erbil 2
Florence 2
Fort Erie 2
Goiânia 2
Guatemala City 2
Guayaquil 2
Karbala 2
Las Vegas 2
Mexico City 2
Miami 2
New Delhi 2
Osio Sotto 2
Ottawa 2
Paris 2
Peschiera Borromeo 2
Totale 1.268
Nome #
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 183
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 173
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 137
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 134
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 134
How to Select the Optimal Candidates for Renal Mass Biopsy 134
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 127
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 126
Pulmonary lesion after surgery for renal cancer: progression or new primary? 124
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 124
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 123
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 122
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 122
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 119
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 111
Parenchymal biopsy in the management of patients with renal cancer 106
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 103
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 101
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 80
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 26
Comprehensive genomic profiling (CGP) of clinical T2-4N0M0 muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatinbased chemotherapy before radical cystectomy (RC) 18
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer 14
Utility of fluoro-deoxy-glucose positron emission tomography (FDG-PET) to predict a pelvic lymph node involvement (LNI) in patients (pts) with muscle-invasive bladder cancer (MIBC) enrolled in neoadjuvant therapy trials 14
The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the Bladder 9
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer 8
Totale 2.472
Categoria #
all - tutte 9.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 1 0 2 0 0 0 0 0 0 0 5
2022/202352 10 9 3 5 3 6 4 6 2 0 1 3
2023/2024186 11 8 12 12 9 35 0 46 0 8 10 35
2024/2025394 28 12 22 30 24 20 55 52 56 22 28 45
2025/20261.732 98 81 113 177 162 59 132 171 459 127 88 65
2026/2027100 50 50 0 0 0 0 0 0 0 0 0 0
Totale 2.472